Glucagon-Like Peptide 1 Receptor Agonists and Risk of Thyroid Cancer: An International Multisite Cohort Study | Thyroid® ⁦@Dr_Aravind_P_MD⁩ ⁦@Unnikri⁩ ⁦@DrIramHussain⁩ ⁦@IrinaBancos⁩ ⁦@MaliniGuptaMD⁩ ⁦@LoriShemek⁩ ⁦